Ryzner Kristi L, Burkiewicz Jill S, Griffin Brooke L, Komperda Kathy E
Department of Pharmacy, Boston Medical Center, Boston, Massachusetts, USA.
Consult Pharm. 2010 Oct;25(10):671-5. doi: 10.4140/TCP.n.2010.671.
to determine patient preference for bisphosphonate therapy based on dosage form and dosing schedule.
prospective telephone survey.
urban community health center.
PATIENTS, PARTICIPANTS: all patients who were seen in the osteoporosis clinic during the 22-month time period were contacted. Patients were excluded if they could not complete the survey in English, had difficulty hearing, had cognitive impairment, or were unable to be reached by telephone.
patients were asked which route and frequency of bisphosphonate therapy was preferred, convenient, and easiest to remember.
MAIN OUTCOME MEASURE(S): patient-reported preference for route and frequency of bisphosphonate administration.
ninety patients were included in the final analysis. Preference for bisphosphonate therapy illustrated that equal numbers of respondents preferred either once-monthly or once-yearly regimens (24.4% for each, n = 22). One-third of respondents (n = 30) indicated that a once-yearly infusion was the most convenient method of administration. The survey revealed no strong association of which regimen was easiest to remember.
the majority of patients preferred once-monthly or less frequent dosing schedules. Clinicians may consider discussing patient preferences during initiation and throughout therapy.
根据剂型和给药方案确定患者对双膦酸盐治疗的偏好。
前瞻性电话调查。
城市社区卫生中心。
患者、参与者:联系了在22个月期间骨质疏松门诊就诊的所有患者。如果患者无法用英语完成调查、听力有困难、有认知障碍或无法通过电话联系到,则将其排除。
询问患者双膦酸盐治疗的哪种途径和频率是首选的、方便的且最容易记住的。
患者报告的双膦酸盐给药途径和频率的偏好。
90名患者纳入最终分析。双膦酸盐治疗的偏好表明,选择每月一次或每年一次治疗方案的受访者人数相等(各占24.4%,n = 22)。三分之一的受访者(n = 30)表示每年一次静脉输注是最方便的给药方法。调查显示,对于哪种治疗方案最容易记住,没有强烈的关联。
大多数患者更喜欢每月一次或更低频率的给药方案。临床医生在开始治疗和整个治疗过程中可考虑讨论患者的偏好。